The U.S. desperately needs more Black and Hispanic doctors, research shows. But financial pressures and discrimination can keep young people from even applying to med school.
Category: NPR
As pandemic emergencies end, some patients with long COVID feel ‘swept under the rug’
Millions of Americans suffer from long COVID, which can have debilitating physical effects, including fatigue and difficulty breathing. Yet many patients feel abandoned, as federal aid winds down.
This GOP member is urging for action on gun control and abortion rights
Rep. Nancy Mace isn’t convinced about some of the stances her party is taking. And she’s already facing blowback for it.
Having diverse doctors saves lives, but students of color face barriers to med school
Research suggests that diversifying the ranks of physicians is critical for saving lives. A new study highlights barriers that keep determined students of color from actually making it to med school.
Why anti-abortion groups are citing the ideas of a 19th-century ‘vice reformer’
Anthony Comstock pushed Congress to crack down on what he saw as harmful vices, such as pornography and contraception. An 1873 law named for him has appeared in recent court battles over abortion.
Out-of-staters flocking to places where abortions are easier to get
States with strong abortion rights protections are seeing many more abortion seekers, mostly from neighboring states with abortion restrictions.
Supreme Court issues a temporary stay in the Texas mifepristone case
The U.S. Supreme Court has issued an administrative stay in a Texas case involving limited access to the abortion drug mifepristone.
As some move on from the pandemic, people with long COVID feel frustrated and alone
There’s deep frustration growing among people with long COVID at the lack of progress in treating the condition.
Here’s what really happened during the abortion drug’s approval 23 years ago
A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here’s what really went down.
The pharmaceutical industry urges courts to preserve access to abortion pill
As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.
